X-irradiation inhibits gastrointestinal absorption of nutrients by damaging the intestinal mucosal cells which actively transport these chemicals. The results of the present study demonstrate that sublethal doses of X-irradiation delay the passive gastrointestinal absorption of an acidic drug, sulfadiazine, and a basic drug, quinine, in mice. This effect is detectable 2 hr after radiation exposure and is most pronounced in the first 3 postirradiation days. Both the magnitude and the duration of the effect are related to the radiation dose (25-300 R in mice and 200-800 R in rats). The effect was not demonstratable when sulfadiazine was given by intraperitoneal or intraduodenal rather than by intragastric administration after which more of the drug was retained in the stomachs of rats irradiated 21 hr earlier. Head irradiation, which is known to delay gastric emptying, lowered blood levels of sulfadiazine after gastric administration, and shielding partially protected against this delayed drug absorption. This effect was most pronounced in whole body irradiated rats. Thus, delayed gastric emptying is the major cause of inhibited gastrointestinal drug absorption in the first 3 days after irradiation of mice and rats.
Skip Nav Destination
Research Article| September 01 1974
Effect of Irradiation on Gastrointestinal Drug Absorption in Mice and Rats
Radiat Res (1974) 59 (3): 606–613.
- Views Icon Views
- Share Icon Share
- Search Site
Aryeh Hurwitz, John Doull; Effect of Irradiation on Gastrointestinal Drug Absorption in Mice and Rats. Radiat Res 1 September 1974; 59 (3): 606–613. doi: https://doi.org/10.2307/3574077
Download citation file:
Citing articles via
Commonalities Between COVID-19 and Radiation Injury
Carmen I. Rios, David R. Cassatt, Brynn A. Hollingsworth, Merriline M. Satyamitra, Yeabsera S. Tadesse, Lanyn P. Taliaferro, Thomas A. Winters, Andrea L. DiCarlo
Monte Carlo Simulation of SARS-CoV-2 Radiation-Induced Inactivation for Vaccine Development
Ziad Francis, Sebastien Incerti, Sara A. Zein, Nathanael Lampe, Carlos A. Guzman, Marco Durante
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
Pataje G. Prasanna, Gayle E. Woloschak, Andrea L. DiCarlo, Jeffrey C. Buchsbaum, Dörthe Schaue, Arnab Chakravarti, Francis A. Cucinotta, Silvia C. Formenti, Chandan Guha, Dale J. Hu, Mohammad K. Khan, David G. Kirsch, Sunil Krishnan, Wolfgang W. Leitner, Brian Marples, William McBride, Minesh P. Mehta, Shahin Rafii, Elad Sharon, Julie M. Sullivan, Ralph R. Weichselbaum, Mansoor M. Ahmed, Bhadrasain Vikram, C. Norman Coleman, Kathryn D. Held
Germicidal Efficacy and Mammalian Skin Safety of 222-nm UV Light
Manuela Buonanno, Brian Ponnaiya, David Welch, Milda Stanislauskas, Gerhard Randers-Pehrson, Lubomir Smilenov, Franklin D. Lowy, David M. Owens, David J. Brenner
RITCARD: Radiation-Induced Tracks, Chromosome Aberrations, Repair and Damage
Ianik Plante, Artem Ponomarev, Zarana Patel, Tony Slaba, Megumi Hada